Novavax | NVAX - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Adma Biologics USD 73.54M 4M 2026-03
Agenus USD 249.24M 74.25M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Cassava Sciences USD 40.11M 3.72M 2026-03
Geron USD 73.57M 40.25M 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
MannKind USD 134.56M 36.47M 2026-03
Merck USD 26.94B 1.38B 2026-03
Minerva Neurosciences USD 2.29M 381K 2025-12
Moderna USD 2.4B 408M 2026-03
Novartis USD 27.28B 4.72B 2025-12
Novavax USD 342.46M 117.49M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Sanofi EUR 30.01B 1.66B 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03